Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elastic NV (ESTC) vs Guardant Health Inc. Common Stock (GH) Price & Performance

Elastic NVTrade
Guardant Health Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Elastic NV vs Guardant Health Inc. Common Stock — how do they compare? Elastic NV trades at $98.5 (market cap $10.00B), while Guardant Health Inc. Common Stock trades at $167.29 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is far larger — about 2.2× Elastic NV's market cap, and Elastic NV is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elastic NV for 10 Days and Guardant Health Inc. Common Stock for 1 Days on average.

ESTCGH
Market Cap
$10.00B$22.22B
Volume
1,610,3371,589,453
Sector
TechnologyHealth
52-Week High
$99.91$187.22
52-Week Low
$43.30$61.73
Typical Hold Time
10 Days1 Days
Enterprise Value
$9.14B$22.86B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elastic NV

Elastic (ESTC) trades at $97.54, up 4.77% on the day, reflecting strong momentum as it approaches resistance near $98. The stock exhibits a bullish technical setup with moving averages supporting the uptrend, though the short-term RSI indicates potential overbought conditions. Fundamentally, the company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, projected to rise from $1.48 billion in 2025 to $1.8 billion in 2026, while net income is expected to swing from a loss to a $376 million profit, signaling improving profitability. Recent news highlights product innovations in AI and observability platforms, reinforcing its competitive edge.

The outlook for ESTC is positive, driven by earnings beats, solid revenue expansion, and strategic product launches in high-growth areas like AI and data search. Key risks include high valuation multiples, such as a P/E of 27.22 and EV/EBITDA of 496.59, which may limit upside if growth slows. Analyst consensus is strongly bullish with a 64.71% buy rating, though the average price target of $79.50 suggests caution relative to the current price. Investors should weigh the strong fundamental trajectory against valuation concerns and market volatility.

Guardant Health Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Elastic NV

Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.

Read more on ESTC →

About Guardant Health Inc. Common Stock

Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.

Read more on GH →